FDA issued a Warning Letter to Hospira Healthcare India Pvt. Ltd. on 5/28/2013 as a result of this inspection.
483 Hospira Healthcare India Oct 2012

483 Hospira Healthcare India Oct 2012

Peter Baker FDA$119.00 - Available Now

FDA investigators audited the Hospira Healthcare India - Sriperumbudur, India facility and issued 5 inspectional observations (via FDA 483) on 10 Oct 2012.

Product details

  • Category: Human Drugs
  • Number of Observations: 5
  • Inspection end: 10 Oct 2012
  • Location: Sriperumbudur, India
  • FEI: 3008386908
Add To Cart